Avisa Pharma developing 10-minute tuberculosis breath test
Avisa Pharma is focusing primarily on tuberculosis detection, with aims to develop a rapid, point-of-care test that could determine if a patient has the disease within 10 minutes.
A breathalyzer that detects diseases like TB, hospital-acquired pneumonia gets funded
Seems these days as though breath analysis startups are all the rage – creating diagnostics that provide quick-turnover disease diagnosis. They’re primarily targeted to the public health set – allowing frontline health workers diagnose disease quickly can help expedite intervention time. New Mexico startup Avisa Pharma is developing a breath-based diagnostic that can rapidly detect […]
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.